GENMAB A/S: ORBIS INVESTMENT MANAGEMENT LTD amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Orbis Investment Management Ltd amended its Schedule 13G filing on Genmab A/S with the SEC under accession number 0000940594-26-000071. The filing updates the investment manager's reported stake in the Danish biotech, though the headline did not disclose the revised share count or percentage. Schedule 13G amendments are typically filed when a passive holder's position moves past disclosure thresholds or otherwise changes materially. Genmab investors will watch for the full filing details to gauge whether Orbis increased or trimmed its holding.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Orbis Investment Management Ltd, Genmab A/S